Paper Details
- Home
- Paper Details
Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Author: KhanMasood A, OwaisMohd
Original Abstract of the Article :
OBJECTIVES: In the present study we evaluated the pharmacokinetics and toxicity of amphotericin B in immunomodulator tuftsin-loaded liposomes in a murine model. METHODS: Stability of amphotericin B liposomes was tested by incubating one volume of liposomal formulations of amphotericin B with nine v...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1093/jac/dkl177
データ提供:米国国立医学図書館(NLM)
Amphotericin B: A Powerful Antifungal with a New Delivery System
Amphotericin B, a powerful antifungal drug, is often used to treat serious fungal infections. However, it can also cause significant side effects. This study investigates the use of liposomes, tiny spheres that can deliver drugs to specific targets, to improve the safety and effectiveness of amphotericin B. This research delves into the exciting world of nanotechnology, exploring its potential to revolutionize drug delivery and treatment.
A Safer and More Effective Amphotericin B
The study demonstrates that encapsulating amphotericin B in liposomes, and even more so, in liposomes containing the immunomodulator tuftsin, significantly reduces the toxicity of the drug while maintaining its antifungal efficacy. This is a significant breakthrough, as it could potentially lead to a safer and more effective treatment for fungal infections.
The Future of Drug Delivery
This research highlights the potential of nanotechnology in improving drug delivery and treatment outcomes. Liposomes offer a promising platform for encapsulating and delivering drugs, reducing toxicity and improving efficacy. This is a testament to the power of innovation in addressing complex medical challenges.
Dr.Camel's Conclusion
This study demonstrates the promising potential of amphotericin B encapsulated in liposomes containing tuftsin. This approach significantly reduces the toxicity of the drug while maintaining its antifungal efficacy. This research highlights the innovative potential of nanotechnology in improving drug delivery and treatment outcomes.
Date :
- Date Completed 2006-09-29
- Date Revised 2013-11-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.